A randomized study showed that a single Revita procedure helped patients retain up to 84% of GLP-1-induced weight loss one year after stopping medication, compared to 46% with sham. No serious device-related adverse events were reported.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.